chr18-65809968-A-G

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_004361.5(CDH7):​c.475A>G​(p.Thr159Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000036 in 1,611,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T159M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

CDH7
NM_004361.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.82

Publications

2 publications found
Variant links:
Genes affected
CDH7 (HGNC:1766): (cadherin 7) This gene encodes a type II classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium dependent cell-cell adhesion molecule is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Type II (atypical) cadherins are defined based on their lack of a histidine-alanine-valine (HAV) cell adhesion recognition sequence specific to type I cadherins. Cadherins mediate cell-cell binding in a homophilic manner, contributing to the sorting of heterogeneous cell types. Mutations in this gene may be associated with bipolar disease in human patients. This gene is present in a gene cluster on chromosome 18. [provided by RefSeq, May 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08276504).
BS2
High AC in GnomAd4 at 33 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH7NM_004361.5 linkc.475A>G p.Thr159Ala missense_variant Exon 3 of 12 ENST00000397968.4 NP_004352.2 Q9ULB5
CDH7NM_001362438.2 linkc.475A>G p.Thr159Ala missense_variant Exon 3 of 12 NP_001349367.1
CDH7NM_033646.4 linkc.475A>G p.Thr159Ala missense_variant Exon 3 of 12 NP_387450.1 Q9ULB5
CDH7NM_001317214.3 linkc.475A>G p.Thr159Ala missense_variant Exon 3 of 11 NP_001304143.1 Q9ULB5F5H5X9Q8IY78

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH7ENST00000397968.4 linkc.475A>G p.Thr159Ala missense_variant Exon 3 of 12 1 NM_004361.5 ENSP00000381058.2 Q9ULB5
CDH7ENST00000323011.7 linkc.475A>G p.Thr159Ala missense_variant Exon 3 of 12 1 ENSP00000319166.3 Q9ULB5
CDH7ENST00000536984.6 linkc.475A>G p.Thr159Ala missense_variant Exon 3 of 11 1 ENSP00000443030.2 F5H5X9

Frequencies

GnomAD3 genomes
AF:
0.000217
AC:
33
AN:
152122
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000676
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000280
AC:
7
AN:
250330
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.000370
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000171
AC:
25
AN:
1459756
Hom.:
0
Cov.:
32
AF XY:
0.0000110
AC XY:
8
AN XY:
725724
show subpopulations
African (AFR)
AF:
0.000628
AC:
21
AN:
33446
American (AMR)
AF:
0.0000224
AC:
1
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39638
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1110156
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000217
AC:
33
AN:
152240
Hom.:
0
Cov.:
31
AF XY:
0.000215
AC XY:
16
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.000674
AC:
28
AN:
41538
American (AMR)
AF:
0.000262
AC:
4
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.537
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000230
Hom.:
0
Bravo
AF:
0.000230
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 23, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.475A>G (p.T159A) alteration is located in exon 3 (coding exon 2) of the CDH7 gene. This alteration results from a A to G substitution at nucleotide position 475, causing the threonine (T) at amino acid position 159 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
20
DANN
Benign
0.92
DEOGEN2
Benign
0.054
T;T;T
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.064
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.74
.;T;T
M_CAP
Benign
0.0042
T
MetaRNN
Benign
0.083
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.0
L;.;L
PhyloP100
2.8
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.1
N;N;N
REVEL
Benign
0.085
Sift
Benign
0.50
T;T;T
Sift4G
Benign
0.50
T;T;T
Polyphen
0.0050
B;B;B
Vest4
0.40
MVP
0.55
MPC
0.35
ClinPred
0.053
T
GERP RS
5.8
Varity_R
0.12
gMVP
0.23
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146356739; hg19: chr18-63477204; COSMIC: COSV59881859; API